Vaxxas
Biotechnology ResearchQueensland, Australia51-200 Employees
Vaxxas, based in Brisbane, Australia, is a biotechnology company developing and commercializing a needle-free vaccine delivery platform intended to improve the performance of vaccines across existing and next-generation formulations. The approach envisions a self-administered patch that could change how vaccines are delivered, reducing reliance on traditional needles. The company operates in the biotechnology research sector and is progressing toward commercialisation of its platform. Its customers and partners include vaccine developers, biopharmaceutical manufacturers, and entities involved in clinical testing. Notable collaborations include SK Bioscience for clinical development and vaccine manufacturing, an integration with Profenso to enable real-time production insights and quality evaluation, and a digital clinical trial arrangement with ObvioHealth. These engagements illustrate the company's focus on supplying technology to support vaccine development, manufacturing, and testing ecosystems.
1-888-653-2347 
support@leadiq.com 
